TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says. November 23, 2005
TCL Archive Panel Calls For New Office, Advisory Groups To Oversee NCI’s Translational Research. June 22, 2007
TCL Archive Accelerated Approval Will No Longer Block Competitors, FDA Commissioner Says June 6, 2003
TCL Archive In Brief: ASTRO Officers Named; AACR Fellowships Available; NRC Won’t Revoke NIH License November 10, 1995
